Blood proteins may help to track the pathological progression of Lewy’s body disease

Early detection of Alzheimer’s disease-related changes in Parkinson’s disease and dementia with Lewy bodies could be made possible by monitoring the amyloid-β (Aβ) and phosphorylated tau (p-tau) proteins. Researchers at

Scientists may have overlooked a hidden Alzheimer’s culprit for decades

For decades, researchers have invested billions of dollars in Alzheimer’s treatments designed to target amyloid beta, a peptide that forms harmful deposits in the brain. But a biochemist at the

Study shows new, more precise way to deliver medicine to the brain

Houston Methodist researchers have discovered a more accurate and timely way to deliver life-saving drug therapies to the brain, laying the groundwork for more effective treatment of brain tumors and